The lipid peroxidation end-product and oxidant 4-hydroxynonenal induces insulin resistance in rat slow-twitch skeletal muscle

References

• Archuleta TL, Lemieux AM, Saengsirisuwan V, et al. (2009). Oxidant stress-induced loss of IRS-1 and IRS-2 proteins in rat skeletal muscle: role of p38 MAPK. Free Radic Biol Med, 47:1486–93
   PubMed Web of Science ®Google Scholar
• Ariano MA, Armstrong RB, Edgerton VR. (1973). Hindlimb muscle fiber populations of five animals. J Histochem Cytochem, 21:51–5
   PubMed Web of Science ®Google Scholar
• Cartee GD, Wojtaszewski JF. (2007). Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport. Appl Physiol Nutr Metabol, 32:557–66
   PubMed Web of Science ®Google Scholar
• DeFronzo RA. (2009). From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes, 58:773–95
   PubMed Web of Science ®Google Scholar
• Demozay D, Mas JC, Rocchi S, Van Obberghen E. (2008). FALDH reverses the deleterious action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal on insulin signaling in 3T3-L1 adipocytes. Diabetes, 57:1216–26
   PubMed Web of Science ®Google Scholar
• Diamond-Stanic MK, Marchionne EM, Teachey MK, et al. (2011). Critical role of transient p38 MAPK activation in skeletal muscle insulin resistance caused by low-level in vitro oxidant stress. Biochem Biophys Res Commun, 405:439–44
   PubMed Web of Science ®Google Scholar
• Dokken BB, Saengsirisuwan V, Kim JS, et al. (2008). Oxidative stress-induced insulin resistance in skeletal muscle: role of glycogen synthase kinase-3. Am J Physiol Endocrinol Metab, 294:E615–21
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Schaur RJ, Zollner H. (1991). Chemistry and biochemistry of 4-hydroxynonenal, malonldehyde and related aldehydes. Free Radic Biol Med, 11:81–128
   PubMed Web of Science ®Google Scholar
• Friedrichsen M, Mortensen B, Pehmøller C, et al. (2013). Exercise-induced AMPK activity in skeletal muscle: role in glucose uptake and insulin sensitivity. Mol Cell Endocrinol, 366:204–14
   PubMed Web of Science ®Google Scholar
• Haber CA, Lam TK, Yu Z, et al. (2003). N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am J Physiol Endocrinol Metab, 285:E744–53
   PubMed Web of Science ®Google Scholar
• Hansen PA, Gulve ES, Holloszy JO. (1994). Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. J Appl Physiol, 76:979–85
   PubMed Web of Science ®Google Scholar
• Henriksen EJ. (2010). Dysregulation of glycogen synthase kinase-3 and the etiology of insulin resistance and type 2 diabetes. Curr Diab Rev, 6:285–93
   PubMedGoogle Scholar
• Henriksen EJ, Bourey RE, Rodnick KJ, et al. (1990). Glucose transporter protein content and glucose transport capacity in rat skeletal muscles. Am J Physiol Endocrinol Metab, 259:E593–8
   PubMed Web of Science ®Google Scholar
• Henriksen EJ, Diamond-Stanic MK, Marchionne EM. (2011). Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med, 51:993–9
   PubMed Web of Science ®Google Scholar
• Henriksen EJ, Halseth AE. (1994). Early alterations in soleus GLUT-4, glucose transport, and glycogen in voluntary running rats. J Appl Physiol, 76:1862–7
   PubMed Web of Science ®Google Scholar
• Hickey MS, Weidner MD, Gavigan KE, et al. (1995). The insulin action-fiber type relationship in humans is muscle group specific. Am J Physiol Endocrinol Metab, 269:E150–9
   Web of Science ®Google Scholar
• Ingram KH, Hill H, Moellering DR, et al. (2012). Skeletal muscle lipid peroxidation and insulin resistance in humans. J Clin Endocrinol Metab, 97:E1182–6
   PubMed Web of Science ®Google Scholar
• Kriketos AD, Pan DA, Lillioja S, et al. (1996). Interrelationships between muscle morphology, insulin action, and adiposity. Am J Physiol Regulatory Integrative Comp Physiol, 270:R1332–9
   PubMed Web of Science ®Google Scholar
• Mattson MP. (2009). Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp Gerontol, 44:625–33
   PubMed Web of Science ®Google Scholar
• Pillon NJ, Croze ML, Vella RE, et al. (2012). The lipid peroxidation by-product 4-hydroxy-2-nonenal (4-HNE) induces insulin resistance in skeletal muscle through both carbonyl and oxidative stress. Endocrinology, 153:2099–111
   PubMed Web of Science ®Google Scholar
• Reaven GM. (1995). Pathophysiology of insulin resistance in human disease. Physiol Rev, 75:473–86
   PubMed Web of Science ®Google Scholar
• Russell AP, Gastaldi G, Bobbioni-Harsch E, et al. (2003). Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids? FEBS Lett, 551:104–6
   PubMed Web of Science ®Google Scholar
• Sano H, Kane S, Sano E, et al. (2003). Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem, 278:14599–602
   PubMed Web of Science ®Google Scholar
• Schaur RJ. (2003). Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol Aspects Med, 24:149–59
   PubMedGoogle Scholar
• Shepherd PR, Kahn BB. (1999). Glucose transporters and insulin action – implications for insulin resistance and diabetes mellitus. N Engl J Med, 341:248–57
   PubMed Web of Science ®Google Scholar
• Wei Y, Sowers JR, Clark SE, et al. (2008). Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kB activation via NADPH oxidase. Am J Physiol Endocrinol Metab, 294:E345–51
   PubMed Web of Science ®Google Scholar
• Yang Y, Sharma R, Sharma A, et al. (2003). Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling. Acta Biochim Pol, 50:319–36
   PubMed Web of Science ®Google Scholar